RECRUITING

Feasibility of Remote Activity Assessment and PRO Collection Among Transgender Cancer Survivors

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Prospective observational feasibility study to evaluate the role of wearable activity monitors to determine the feasibility and acceptability of remote monitoring using wearable technology and PROs to monitor fatigue and physical function in transgender cancer patients and survivors.

Official Title

Study to Remotely Monitor Activity in Transgender Cancer Survivors

Quick Facts

Study Start:2023-02-01
Study Completion:2025-07-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05391217

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Self-identifies as transgender person with a history of cancer or receiving treatment for cancer in the last five years from screening for the current study (case) OR self-identifies as transgender person without a history of cancer (control)
  2. * 18 years or older
  3. * Ambulatory (use of walking aids, such as cane and rollator, is acceptable)
  4. * Access to a device (e.g., smartphone, tablet, iPhone) that has the capability to sync to the Fitbit
  5. * Have an understanding, ability, and willingness to fully comply with study procedures and restrictions
  6. * Can read and understand English, Spanish, or Tagalog (for participant surveys and interviews)
  7. * Informed consent obtained from subject and ability for subject to comply with the requirements of the study.
  1. * Any person that does not meet the listed criteria above
  2. * Using a pacemaker, implantable cardiac defibrillator, neurostimulator, implantable hearing aids, cochlear implants, or other electronic medical equipment\*. However, removable hearing aids are permitted.

Contacts and Locations

Study Contact

Gillian Gresham
CONTACT
310-423-3341
gillian.gresham@cshs.org

Principal Investigator

Gillian Gresham, PhD
PRINCIPAL_INVESTIGATOR
Cedars-Sinai Medical Center

Study Locations (Sites)

Cedars-Sinai Medical Center
Los Angeles, California, 90048
United States

Collaborators and Investigators

Sponsor: Cedars-Sinai Medical Center

  • Gillian Gresham, PhD, PRINCIPAL_INVESTIGATOR, Cedars-Sinai Medical Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-02-01
Study Completion Date2025-07-01

Study Record Updates

Study Start Date2023-02-01
Study Completion Date2025-07-01

Terms related to this study

Additional Relevant MeSH Terms

  • Neoplasms
  • Chronic Disease